|
Astorg and International Chemical Investors Group ("ICIG") today announce that they have signed a binding agreement whereby Astorg will acquire CordenPharma ("CordenPharma" or the "Company"), a global leading pharmaceutical CDMO (Contract Development Manufacturing Organisation) with highly differentiated capabilities in Active Pharmaceutical Ingredients, Excipients, and Drug Products, from ICIG.
As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg. The Company has experienced strong organic growth thanks to its position in complex and fast-growing drug modalities including mRNA vaccines, peptides and high-potency compounds notably for oncology therapeutics.
Established in 2006, CordenPharma today...
|